New ACTIVEFOCUS™ Intraocular Lens Offers Cataract Patients Unprecedented Results

Having recently received FDA approval, ACTIVEFOCUS^™ is a groundbreaking Intraocular Lens (IOL) option with a unique design. ACTIVEFOCUS^™ is the only multifocal toric IOL with the center being completely dedicated to distance vision, which provides enhanced results for patients when viewing objects far away, as well as an overall improved range of vision. This offers cataract patients with astigmatism and presbyopia advanced potential compared to traditional IOLs.

Dr. Stephen V. Scoper was the first in Virginia to implant this innovative ACTIVEFOCUS^™ IOL, and he has found it to provide exceptional results. He says ACTIVEFOCUS^™ is “not just another multifocal,” it has transformed the way he cares for cataract patients.

Due to Dr. Scoper’s particular expertise with the new ACTIVEFOCUS^™, he had the opportunity to present his findings at the IOL’s official launch during the American Society of Cataract and Refractive Surgery’s recent conference. With about 4,500 cataract surgeries performed at our practice each year, he looks forward to better customizing treatment to patients’ needs and lifestyles using the new ACTIVEFOCUS^™ IOL design.

To learn more about Dr. Scoper’s experience with this revolutionary new IOL, you can watch his interview with Alcon below: